BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36145490)

  • 1. SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods.
    Berno G; Fabeni L; Matusali G; Gruber CEM; Rueca M; Giombini E; Garbuglia AR
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.
    Umunnakwe CN; Makatini ZN; Maphanga M; Mdunyelwa A; Mlambo KM; Manyaka P; Nijhuis M; Wensing A; Tempelman HA
    PLoS One; 2022; 17(6):e0269071. PubMed ID: 35749403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
    Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
    Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan.
    Kairov U; Amanzhanova A; Karabayev D; Rakhimova S; Aitkulova A; Samatkyzy D; Kalendar R; Kozhamkulov U; Molkenov A; Gabdulkayum A; Sarbassov D; Akilzhanova A
    Front Genet; 2022; 13():906318. PubMed ID: 36118859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites.
    Ham RE; Smothers AR; Che R; Sell KJ; Peng CA; Dean D
    Microbiol Spectr; 2022 Jun; 10(3):e0079722. PubMed ID: 35546574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing.
    Arévalo MT; Karavis MA; Katoski SE; Harris JV; Hill JM; Deshpande SV; Roth PA; Liem AT; Bernhards RC
    Front Microbiol; 2022; 13():910955. PubMed ID: 35733956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
    Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Whole-Genome Sequencing Using Oxford Nanopore Technology for Variant Monitoring in Wastewaters.
    Barbé L; Schaeffer J; Besnard A; Jousse S; Wurtzer S; Moulin L; ; Le Guyader FS; Desdouits M
    Front Microbiol; 2022; 13():889811. PubMed ID: 35756003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2.
    Brinkmann A; Ulm SL; Uddin S; Förster S; Seifert D; Oehme R; Corty M; Schaade L; Michel J; Nitsche A
    Front Microbiol; 2021; 12():651151. PubMed ID: 34276587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
    Hahn G; Wu CM; Lee S; Lutz SM; Khurana S; Baden LR; Haneuse S; Qiao D; Hecker J; DeMeo DL; Tanzi RE; Choudhary MC; Etemad B; Mohammadi A; Esmaeilzadeh E; Cho MH; Li JZ; Randolph AG; Laird NM; Weiss ST; Silverman EK; Ribbeck K; Lange C
    Genet Epidemiol; 2021 Oct; 45(7):685-693. PubMed ID: 34159627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in Gabon.
    Lekana-Douki SE; N'dilimabaka N; Levasseur A; Colson P; Andeko JC; Zong Minko O; Banga Mve-Ella O; Fournier PE; Devaux C; Ondo BM; Akombi FL; Yacka Mouele Bolo L; Ngonga Dikongo AM; Diané A; Mabika Mabika A; Mathouet JF; Dzembo C; Atiga NC; Mouity Matoumba A; Ndjangangoye NK; Bréchard L; Bedotto-Buffet M; Mangombi Pambou JB; Kandet Yattara M; Mbongo Nkama EA; Mintsa Ndong A; Adegnika AA; Raoult D; Fenollar F; Lekana-Douki JB
    Front Med (Lausanne); 2022; 9():877391. PubMed ID: 35655849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.
    Kuchinski KS; Jassem AN; Prystajecky NA
    J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
    Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
    Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients.
    Alotaibi B; El-Masry TA; Seadawy MG; El-Harty BE; Saleh A; Gad AF; El-Hosseny MF; Mahran YF; El-Bouseary MM
    Infect Genet Evol; 2022 Jun; 100():105278. PubMed ID: 35367360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.